These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 23827912

  • 1. [Evaluation of a program of application of the botulinum toxin type A in children with cerebral palsy in Vale do Jequitinhonha].
    Silva GF, Teles MC, Santos SA, Ferreira FO, Almeida KM, Camargos AC.
    Cien Saude Colet; 2013 Jul; 18(7):2075-84. PubMed ID: 23827912
    [Abstract] [Full Text] [Related]

  • 2. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
    Lin YC, Lin IL, Chou TF, Lee HM.
    J Neuroeng Rehabil; 2016 Mar 12; 13():25. PubMed ID: 26969526
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
    Williams SA, Elliott C, Valentine J, Gubbay A, Shipman P, Reid S.
    Disabil Rehabil; 2013 Apr 12; 35(7):596-605. PubMed ID: 22928803
    [Abstract] [Full Text] [Related]

  • 5. Effects of botulinum toxin serotype A on sleep problems in children with cerebral palsy and on mothers sleep quality and depression.
    Binay Safer V, Ozbudak Demir S, Ozkan E, Demircioglu Guneri F.
    Neurosciences (Riyadh); 2016 Oct 12; 21(4):331-337. PubMed ID: 27744462
    [Abstract] [Full Text] [Related]

  • 6. The utility of shear wave elastography in the evaluation of muscle stiffness in patients with cerebral palsy after botulinum toxin A injection.
    Dağ N, Cerit MN, Şendur HN, Zinnuroğlu M, Muşmal BN, Cindil E, Oktar SÖ.
    J Med Ultrason (2001); 2020 Oct 12; 47(4):609-615. PubMed ID: 32705628
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K, Hays R, Graubert C, Price R, Won F, McLaughlin JF, Cohen M.
    Pediatrics; 2007 Jul 12; 120(1):49-58. PubMed ID: 17606561
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
    Mirska A, Cybula K, Okurowska-Zawada B, Kułak W, Dmitruk E, Okulczyk K, Kalinowska AK.
    J Pediatr Orthop B; 2014 Nov 12; 23(6):517-22. PubMed ID: 25171568
    [Abstract] [Full Text] [Related]

  • 12. Development of an inventory of goals using the International Classification of Functioning, Disability and Health in a population of non-ambulatory children and adolescents with cerebral palsy treated with botulinum toxin A.
    Nguyen L, Mesterman R, Gorter JW.
    BMC Pediatr; 2018 Jan 04; 18(1):1. PubMed ID: 29301539
    [Abstract] [Full Text] [Related]

  • 13. Effect of botulinum toxin type a combined with physical therapy on functional capacity in children with spastic cerebral palsy: a randomized controlled clinical trial.
    de Souza ME, Razera Ferreira C, Santos Oliveira C, Molledo Secco MF, Fonseca Junior P, Roberto Garcia Lucareli P, Biasotto-Gonzalez DA, Politti F.
    Neurol Res; 2024 Sep 04; 46(9):796-802. PubMed ID: 38797512
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar 04; 20(114):68. PubMed ID: 21648226
    [No Abstract] [Full Text] [Related]

  • 15. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
    Kay RM, Rethlefsen SA, Fern-Buneo A, Wren TA, Skaggs DL.
    J Bone Joint Surg Am; 2004 Nov 04; 86(11):2377-84. PubMed ID: 15523006
    [Abstract] [Full Text] [Related]

  • 16. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
    Pascual-Pascual SI, Pascual-Castroviejo I, Ruiz PJ.
    Am J Phys Med Rehabil; 2011 Jul 04; 90(7):554-63. PubMed ID: 21765274
    [Abstract] [Full Text] [Related]

  • 17. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
    Fazzi E, Maraucci I, Torrielli S, Motta F, Lanzi G.
    J Child Neurol; 2005 Aug 04; 20(8):661-6. PubMed ID: 16225811
    [Abstract] [Full Text] [Related]

  • 18. A French observational study of botulinum toxin use in the management of children with cerebral palsy: BOTULOSCOPE.
    Chaléat-Valayer E, Parratte B, Colin C, Denis A, Oudin S, Bérard C, Bernard JC, Bourg V, Deleplanque B, Dulieu I, Evrard P, Filipetti P, Flurin V, Gallien P, Héron-Long B, Hodgkinson I, Husson I, Jaisson-Hot I, Maupas E, Meurin F, Monnier G, Pérennou D, Pialoux B, Quentin V, Moreau MS, Schneider M, Yelnik A, Marque P.
    Eur J Paediatr Neurol; 2011 Sep 04; 15(5):439-48. PubMed ID: 21745754
    [Abstract] [Full Text] [Related]

  • 19. [Botulinum toxin type A for the treatment of spasticity in children with cerebral palsy].
    Dimitrijević L, Stanković I, Zivković V, Mikov A, Colović H, Janković I.
    Vojnosanit Pregl; 2007 Aug 04; 64(8):513-8. PubMed ID: 17874717
    [Abstract] [Full Text] [Related]

  • 20. Botulinum Toxin Type A in the Spasticity of Cerebral Palsy Related to Congenital Zika Syndrome: An Observational Study.
    Armani-Franceschi G, Luz C, Lucena PH, d'Afonseca D, Sales H, Carvalho AL, Siqueira IC, Silva K, Portuense S, Monteiro L, Bandeira ID, Melo A, Lucena R.
    Dev Neurorehabil; 2022 Apr 04; 25(3):162-169. PubMed ID: 34387523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.